Women with small breasts often believe they are cursed, and openly feel envious of those with bigger breasts. However, there are actually some benefits of having smaller breasts. Stop stuffing tissues into your bras and forget about breast implant surgery, girls. Be proud of being small-chested...
Breastfeeding is associated with a risk reduction for several acute and chronic diseases in women and their infants. Health benefits of breastfeeding are especially important for small, sick and preterm infants. The objective of this article is to summarize essential steps for healthcare personnel ...
CONCLUSIONS: Soy intake may be associated with a small reduction in breast cancer risk. However, this result should be interpreted with caution due to ... BJ Trock,HC Leena,C Robert - 《J Natl Cancer Inst》 被引量: 863发表: 2006年 Population-based case-control study of soyfood intake ...
that long term use of hormonal supplements in postmenopausal women may be responsible for an average net loss of years of life.1 Far more studies have been done that show benefits of hormone replacement therapy on coronary heart disease and osteoporosis than that show benefits on breast cancer. ...
For women between ages 50 and 69, the benefits were somewhat lower for both time to recurrence (53.4% vs 57.6% control) and mortality (47.4% vs 50.4% control). More recent clinical investigations have largely focused on optimizing treatment for three clinical subgroups: ER+HER2−, HER2+, ...
Nevertheless, the clinical application of targeted therapies have thus far provided limited clinical benefits for lung ADC patients6,7. Accumulating evidence has supported the oncogenic functions of trefoil factor 3 (TFF3) in promoting tumor progression8,9,10. TFF3 expression is increased in a number...
We further uncovered the benefits of ERβ conjugates in the skin using two inducible skin injury mouse models, showing increased skin basal cell proliferation, epidermal thickness, and wound healing. Therefore, our ERβ-selective agonist conjugates offer novel therapeutic potential to improve aging-...
durvalumab and placebo groups, respectively (HR = 0.72; 95% CI = 0.59–0.89). These results have significant implications for unresectable stage III patients. Consistent with previous reports, OS and PFS benefits with durvalumab compared with placebo were observed in all prespecified ...
The benefits are linked to availing of antenatal check-ups by the pregnant woman and getting her delivery conducted in a healthcare facility. Although the beneficiaries are encouraged to register themselves with the health workers at the subcentres, Anganwadis or PHCs for availing of at least ...
such as combining c-Met inhibitors with HGF neutralizing antibodies, and cooperatively targeting upstream, downstream or parallel signaling, can not only improve the clinical benefits but also overcome drug resistance to c-Met inhibitors. Such strategies may also benefit a wide range of patients who ...